Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Motor Fluctuations”

135 trials

Showing 20 of 135 results

Post-approval studies (Phase 4)Study completedNCT05312632
What this trial is testing

Evaluate the Efficacy and Safety of Safinamide Mesilate as Add-on Therapy to Levodopa in Parkinson's Disease Participants With Motor Fluctuation in South Korea

Who this might be right for
Parkinson Disease
Eisai Korea Inc. 201
Post-approval studies (Phase 4)Study completedNCT04986995
What this trial is testing

OpicApone Sleep dISorder

Who this might be right for
Parkinson Disease
Bial - Portela C S.A. 22
Not applicableLooking for participantsNCT02060695
What this trial is testing

Temporal Relationship Between Motor Fluctuations and Nonmotor Fluctuations

Who this might be right for
Parkinson Disease
Seoul National University Hospital 800
Large-scale testing (Phase 3)Study completedNCT00357994
What this trial is testing

Study of Efficacy, Safety and Tolerability of Levodopa-Carbidopa Intestinal Gel in Levodopa-Responsive Parkinson's Subjects

Who this might be right for
Advanced Parkinson's Disease
AbbVie (prior sponsor, Abbott) 36
Not applicableNot Yet RecruitingNCT07074119
What this trial is testing

Sensor-Based Optimization of Therapy for Parkinson's Disease Patients With Motor Fluctuations

Who this might be right for
Parkinson Disease (PD)
Assistance Publique - Hôpitaux de Paris 218
Large-scale testing (Phase 3)Study completedNCT02240030
What this trial is testing

Efficacy and Safety Study of CVT-301 In Parkinson's Disease Patients With OFF Episodes

Who this might be right for
Idiopathic Parkinson's Disease
Acorda Therapeutics 351
Very early researchStudy completedNCT01151111
What this trial is testing

Relaxation Guided Imagery for Treatment of Parkinson's Disease

Who this might be right for
Parkinson's Disease
Rambam Health Care Campus 20
Testing effectiveness (Phase 2)Study completedNCT00914602
What this trial is testing

An Exploratory Study of XP21279 (With Lodosyn®) and Sinemet® in Parkinson's Disease Subjects

Who this might be right for
Parkinson's Disease
XenoPort, Inc. 14
Testing effectiveness (Phase 2)Study completedNCT01341431
What this trial is testing

Bee Venom for the Treatment of Parkinson Disease

Who this might be right for
Parkinson Disease
Assistance Publique - Hôpitaux de Paris 50
Large-scale testing (Phase 3)Study completedNCT02242487
What this trial is testing

Twelve Month Safety and Efficacy Study of CVT-301 In Parkinson's Disease Patients With OFF Episodes

Who this might be right for
Idiopathic Parkinson's Disease
Acorda Therapeutics 325
Not applicableLooking for participantsNCT04366804
What this trial is testing

International Validation of Two Non-motor Scales in PD (NFS and SPARK)

Who this might be right for
Parkinson's DiseaseNon-motor Symptoms
Insel Gruppe AG, University Hospital Bern 300
Early research (Phase 1)Study completedNCT02812394
What this trial is testing

Compare Two Dose Strengths of CVT-301 (Levodopa Inhalation Powder) With an Oral Dose of Sinemet® (Carbidopa-levodopa) Tablets

Who this might be right for
Parkinson Disease
Acorda Therapeutics 24
Testing effectiveness (Phase 2)Study completedNCT04191577
What this trial is testing

Study of CVN424 in Parkinson's Disease Patients With Motor Fluctuations

Who this might be right for
Parkinson Disease
Cerevance Beta, Inc. 136
Not applicableStudy completedNCT06214377
What this trial is testing

Transcranial Direct Current Stimulation for Treating Parkinson´s Disease-related Pain in OFF State

Who this might be right for
Parkinson DiseasePain
Universidad Francisco de Vitoria 15
Testing effectiveness (Phase 2)Study completedNCT04332276
What this trial is testing

Dopaminergic RestauratIon by IntraVEntriculaire Administration

Who this might be right for
Parkinson Disease
University Hospital, Lille 12
Large-scale testing (Phase 3)Study completedNCT01479530
What this trial is testing

Azilect® (Rasagiline) in Levodopa-treated Parkinson's Patients With Motor Fluctuations in China

Who this might be right for
Parkinson's Disease
H. Lundbeck A/S 321
Large-scale testing (Phase 3)Study completedNCT00335153
What this trial is testing

Levodopa-Carbidopa Intestinal Gel Open-Label Study in Advanced Parkinson's Disease

Who this might be right for
Advanced Parkinson's Disease
AbbVie (prior sponsor, Abbott) 354
Large-scale testing (Phase 3)Ended earlyNCT00505622
What this trial is testing

Evaluation of the Long-term Safety, Tolerability, and Efficacy of Perampanel (E2007) as an Adjunctive Therapy in Levodopa Treated Parkinson's Disease Subjects With Motor Fluctuations

Who this might be right for
Parkinson's Disease
Eisai Limited 328
Large-scale testing (Phase 3)Study completedNCT02542696
What this trial is testing

Open-Label Phase 3 Study to Examine the Long-Term Safety, Tolerability and Efficacy of APL-130277 for the Acute Treatment of "OFF" Episodes in Patients With Parkinson's Disease

Who this might be right for
Parkinson Disease
Sumitomo Pharma America, Inc. 496
Large-scale testing (Phase 3)Study completedNCT00660673
What this trial is testing

Open Label Continuation Treatment Study With Levodopa-Carbidopa Intestinal Gel in Advanced Parkinson's Disease

Who this might be right for
Advanced Parkinson's Disease
AbbVie 262
Load More Results

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation